Position in GRAL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,369,322
+$2,721,459 QoQ
Shares Held
151,887
+2.6% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 374 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $7,235,188,048 across 26 Diagnostics & Research names. GRAL ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,271,514 | $3,645,646,251 | |
| 2 | NTRA |
Natera, Inc.
|
2,725,903 | $739,946,367 | |
| 3 | DHR |
Danaher Corp /De/
|
3,687,390 | $702,374,042 | |
| 4 | GH |
Guardant Health, Inc.
|
3,236,065 | $485,506,829 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,105,185 | $406,763,838 | |
| 6 | WAT |
Waters Corp /De/
|
809,339 | $303,534,496 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
575,784 | $303,115,723 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,225,769 | $162,818,892 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,369,322 | 151,887 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,647,863 | 147,985 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,507,693 | 146,135 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $272,349 | 4,606 | Shares | Defined | 2025-11-13 | |
| 2024-06-30 | $807,953 | 52,567 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||